Oxbryta & Sickle cell anaemia with crisis

39.4%

of users reported Sickle cell anaemia with crisis

90.8%

also reported Hospitalization

62.4%

are women

Hospitalization

90.8%

Severe reaction

8.8%

Death

0.2%

Life-threatening condition

<0.1%

Disability

<0.1%

Oxbryta: general information

0 - 9 years

1.2%

10 - 19 years

18.8%

20 - 29 years

20.0%

30 - 39 years

24.0%

40 - 49 years

16.0%

50 - 59 years

13.6%

60 - 69 years

5.7%

70 - 79 years

0.8%